About Us
Senya Therapeutics is a newly formed spinout of University College London based in Central London. We have inherited data, knowhow and an extensive portfolio of patents related to a novel target called glycoprotein leucine-rich α-2 glycoprotein 1 (LRG1).
Why Work With Us
Vacancies
Interested In
Working With Us?
We are planning to recruit Chief Scientific Officer, Head of Translational Medicine and Project Manager, Pre-Clinical programmes in 2024. If you would like us to inform you, could you register your interest by send an email with your CV to info@senyatx.com